Wockhardt kickstarts Global Phase 3 Clinical Study of its novel antibiotic WCK 5222

WCK 5222 is a super-drug, an entirely new class of antibiotic known as ‘β-lactam ENHANCER’.

Related Keywords

China ,United States ,India ,America , ,Wockhardt Limited ,Clinical Study ,Complicated Urinary Tract Infections ,